66--ILLUMINA INC iSelect 8x1 LCG Custom DNA Analysis Kit
ID: 75N92025Q1139Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NHLBIBETHESDA, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/609f64721f7344db896c1681304dae68/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure the ILLUMINA INC iSelect 8x1 LCG Custom DNA Analysis Kit. This procurement aims to acquire a specialized DNA analysis kit that is essential for various research and clinical applications within the NIH's National Heart, Lung, and Blood Institute (NHLBI). The kit is crucial for advancing genomic research and enhancing the understanding of genetic factors related to health and disease. Interested vendors can reach out to Helmut Winffel at helmut.winffel@nih.gov or call 301-435-0330 for further details regarding this presolicitation opportunity.

    Point(s) of Contact
    Winffel, Helmut
    (301) 435-0330
    helmut.winffel@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    66--ILLUMINA INC iSelect 8x1 LCG Custom DNA Analysis Kit
    Currently viewing
    Presolicitation
    Similar Opportunities
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Q--Jackson Heart Study Whole Genome Sequencing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the Jackson Heart Study Whole Genome Sequencing project. This initiative aims to conduct comprehensive whole genome sequencing to enhance understanding of cardiovascular health within the Jackson Heart Study cohort. The services procured will play a crucial role in advancing medical research and improving health outcomes related to heart disease. Interested parties can reach out to Helmut Winffel at helmut.winffel@nih.gov or call 301-435-0330 for further details regarding the presolicitation notice.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for biomarkers abeta42, abeta40, and pTau 217, which will be utilized in research involving stored samples from the Baltimore Longitudinal Study of Aging (BLSA) to assess cognitive decline and neurodegeneration. This procurement is critical for advancing Alzheimer’s research and will be awarded as a firm fixed-price purchase order, with quotations due by 5:00 p.m. Eastern Time on January 8, 2025. Interested vendors should contact Iris Merscher at iris.merscher@nih.gov for further details.
    6640--NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole-source contract to Illumina, Inc. for the provision of molecular testing reagents required by the Minneapolis VA Health Care System. This procurement involves a Firm Fixed Price Purchase Order for a base year plus four option years, specifically for next-generation sequencing reagents that are compatible with the VA's existing Illumina sequencers. The sole-source justification is based on the fact that Illumina is the only authorized supplier for these specialized reagents, with no alternative products approved for use on the VA's equipment. Interested vendors who believe they can meet the requirements are encouraged to submit capability statements by January 10, 2025, to the Contracting Officer, Traci Johannes, at traci.johannes@va.gov.
    A--National Gene Vector Biorepository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) to support gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract aims to provide essential resources and services, including administrative management, core laboratory activities, and compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is crucial for advancing gene therapy capabilities and ensuring the proper archiving of biological specimens and development of assays. Proposals must be submitted by January 10, 2025, and should include detailed technical and business plans, with specific formatting guidelines and a budget submission required. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153.
    NHLBI Procurement Forecast - FY2025-Q1 & Q2
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), has issued a special notice regarding its procurement forecast for the first and second quarters of Fiscal Year 2025. This notice outlines anticipated contracting opportunities, including a variety of goods and services such as scientific support services, IT security, and specialized scientific equipment, with a focus on fostering small business participation. The forecast serves as a planning tool for potential vendors, indicating that while the projected procurements are subject to change, they are essential for supporting the NIH's mission in health research. Interested parties can find detailed information, including estimated dollar values and points of contact, in the attached document, with initial award dates ranging from late 2024 to mid-2025.
    Ongoing Monoclonal Antibodies and Plasmids Services through GENSCRIPT
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with GenScript USA Inc. for ongoing monoclonal antibodies and plasmids services. The procurement aims to support the NIAID Laboratory of Immunogenetics (LIG) in advancing research on human B cells and the isolation of monoclonal antibodies, which are critical for developing new vaccine candidates against influenza. This contract is a continuation of existing services that require continuity for accurate comparison of results, and interested parties may submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by January 3, 2025, at 5:00 PM ET. For further inquiries, contact Dana Monroe at dana.monroe@nih.gov or call 406-375-9814.
    65--Notice of Intent to Sole Source
    Active
    Environmental Protection Agency
    The Environmental Protection Agency (EPA) has issued a Notice of Intent to Sole Source for Lexogen Molecular Kits, which are essential for various analytical applications. This procurement falls under the NAICS code 334516, focusing on Analytical Laboratory Instrument Manufacturing, and is categorized under PSC code 6550 for in vitro diagnostic substances, reagents, test kits, and sets. The kits are critical for supporting the EPA's mission in environmental monitoring and research. Interested parties can reach out to Agnes Choate at Choate.Agnes@epa.gov or call 919-541-2579 for further information regarding this opportunity.
    Orbitor RS2 Microplate Robotic Bundle with Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through its National Institute of Allergy and Infectious Diseases (NIAID), intends to procure an Orbitor RS2 Microplate Robotic Bundle with integrated software for its Vaccine Immunology Program (VIP) within the Vaccine Research Center (VRC). This procurement aims to automate the handling and analysis of Mabtech Fluorospot Assays, which are critical for evaluating T-cell responses in clinical trials, thereby enhancing the efficiency and accuracy of vaccine research. The equipment must meet specific technical requirements, including compatibility with existing lab systems and advanced features such as a bi-directional telescoping arm and Momentum™ scheduling software. Interested vendors are invited to submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by January 3, 2025, at 5:00 PM ET, with all submissions considered by the Government at its discretion.
    Nova Benchtop System
    Active
    Dept Of Defense
    The Department of Defense, through the United States Army Medical Research Acquisition Activity (USAMRAA), intends to negotiate a sole source contract with Helix Biotech for the acquisition of a Nova Benchtop Microfluidics device. This procurement aims to secure a chip-less, scalable, and highly flexible modular system essential for the encapsulation of mRNA for cellular delivery, including all necessary ancillary components, delivery, self-installation with virtual support, training, and a one-year manufacturer warranty. The device is critical for producing lipid nanoparticles, which play a significant role in various biomedical applications. Interested parties may submit their capability information by 2:00 p.m. Eastern Time on January 16, 2025, to Ms. Natalie Bethel at natalie.l.bethel2.civ@health.mil, as this notice is not a request for competitive quotations.